8-K
filed October 2, 2024, 7:59 PM ET
ticker VERA
CIK 0001831828
other material
confidence high
sentiment positive
materiality 0.60
Vera expands atacicept program to broader IgAN and autoimmune kidney diseases with two new studies
Vera Therapeutics, Inc.
- ORIGIN Extend to start Q4 2024, providing extended atacicept access and long-term data for ORIGIN participants.
- PIONEER study in 2025 will evaluate atacicept in expanded IgAN populations (low eGFR, high/low proteinuria, recurrence post-transplant, adolescents) and podocytopathies (pMN, FSGS, MCD).
- Combined US peak prevalence of IgAN and autoimmune-driven pMN, FSGS, MCD estimated at ~230,000.
- 96-week Phase 2b ORIGIN data to be presented as Late Breaking Oral at ASN Kidney Week 2024.
- Multiple regulatory and clinical milestones expected over next 18 months.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-24-230760
- form_type
- 8-K
- ticker
- VERA
- cik
- 0001831828
- company_name
- Vera Therapeutics, Inc.
- filed_at
- 2024-10-02T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:09.904540+00:00
- generated_at
- 2026-05-30T22:47:17.491930+00:00
- sec_items
- ["7.01", "9.01"]
- event_type
- other_material
- sentiment
- positive
- materiality_score
- 0.6
- calibrated_materiality_score
- 0.6
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-24-230760
- json_url
- https://secwatch.observer/filing/0001193125-24-230760.json
- markdown_url
- https://secwatch.observer/filing/0001193125-24-230760.md
- text_url
- https://secwatch.observer/filing/0001193125-24-230760.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1831828/000119312524230760/0001193125-24-230760-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1831828/000119312524230760/d802938d8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
TOYOTA MOTOR CREDIT CORP
TMCC reports FY2026 net income up 35% to $2.31B; credit losses improve to 0.80%
TOYOTA MOTOR CREDIT CORP
June 2, 2026, 12:20 PM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
VTIX
Virtuix amends warrants to $4.00 exercise price, extends period to July 27, 2026
Virtuix Holdings Inc.
June 2, 2026, 9:15 AM ET
other_material
Items 1.01, 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
OMQS
OMNIQ notes $170B in border security funding driving AI machine vision demand
OMNIQ Corp.
June 2, 2026, 8:45 AM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
SPAI
Safe Pro receives $743K U.S. Army order for AI-powered threat analysis kit with Red Cat drones
Safe Pro Group Inc.
June 2, 2026, 8:41 AM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
OLOX
Olenox reports May 2026 Bitcoin production of 18.6 BTC; first update after CS Digital acquisition
OLENOX INDUSTRIES INC.
June 2, 2026, 8:30 AM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
MBOT
Microbot Medical secures first North Carolina customer for LIBERTY robotic system
Microbot Medical Inc.
June 2, 2026, 8:30 AM ET
other_material
Items 7.01, 8.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
UIS
Unisys issues upwardly revised FY2026 revenue guidance at Investor Day, no specific figures in filing
UNISYS CORP
June 2, 2026, 8:04 AM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
BJDX
Bluejay Diagnostics partners with Argonaut for US-based Symphony platform manufacturing
Bluejay Diagnostics, Inc.
June 2, 2026, 6:30 AM ET
other_material
Items 1.01, 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.